Paper · 39199682
Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation.
Hackner D and 6 others. Cancers (Basel), 2024. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation. Papers, record 39199682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199682
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,540,286 | Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31540286 | PubMed |
| 2 | 32,366,995 | Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. | Eur J Clin Nutr | 2020 | https://conductscience.org/library/papers/32366995 | PubMed |
| 3 | 37,239,137 | Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma-A Single-Center Evaluation. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239137 | PubMed |
| 4 | 25,431,369 | Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. | HPB (Oxford) | 2015 | https://conductscience.org/library/papers/25431369 | PubMed |
| 5 | 32,782,024 | Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32782024 | PubMed |
| 6 | 33,802,006 | The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33802006 | PubMed |
| 7 | 30,341,417 | Optimizing the outcomes of pancreatic cancer surgery. | Nat Rev Clin Oncol | 2019 | https://conductscience.org/library/papers/30341417 | PubMed |
| 8 | 7,165,009 | Toxicity and response criteria of the Eastern Cooperative Oncology Group. | Am J Clin Oncol | 1982 | https://conductscience.org/library/papers/7165009 | PubMed |
| 9 | 25,635,347 | A new initiative on precision medicine. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25635347 | PubMed |
| 10 | 34,511,190 | Precision Medicine and Pancreatic Cancer. | Surg Oncol Clin N Am | 2021 | https://conductscience.org/library/papers/34511190 | PubMed |
1 to 10 of 28
See all 28 referencesCited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,588,591 | Integration of Preoperative Neutrophil-to-Lymphocyte Ratio into Machine Learning Models for Predicting Lymph Node Metastasis in CRC. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588591 | PubMed |
| 42,587,141 | Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic ductal adenocarcinoma. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42587141 | PubMed |
| 42,512,376 | Inflammation-Based Hematological Indices (NLR, PLR, LMR) in Pancreatic Cancer: Implications for Laboratory Diagnostics and Clinical Interpretation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512376 | PubMed |
| 42,226,668 | Dynamic Prognostic Nutritional Index With Circulating Tumor DNA Predicts Survival in Localized Pancreatic Ductal Adenocarcinoma. | J Surg Oncol | 2026 | https://conductscience.org/library/papers/42226668 | PubMed |
| 41,892,325 | ChemoNETosis in Cancer: A Comprehensive Review of Treatment-Induced NET Formation and Therapeutic Consequences. | Cells | 2026 | https://conductscience.org/library/papers/41892325 | PubMed |
| 41,827,717 | Endoscopic Ultrasound-Guided Versus Percutaneous Transhepatic Biliary Drainage After Failed Endoscopic Retrograde Cholangiopancreatography in Malignant Biliary Obstruction: A Single-Center Retrospective Cohort. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41827717 | PubMed |
| 41,484,243 | Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic ductal adenocarcinoma. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/41484243 | PubMed |
| 41,212,253 | Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma. | Eur Radiol | 2026 | https://conductscience.org/library/papers/41212253 | PubMed |
| 40,665,634 | GPRC5A/CXCL8/NLRP3-mediated neutrophil extracellular traps drive gemcitabine-nab-paclitaxel resistance in pancreatic adenocarcinoma. | Cancer Biol Med | 2025 | https://conductscience.org/library/papers/40665634 | PubMed |
| 40,361,375 | Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curative Surgery for Pancreatic Ductal Adenocarcinoma: A Cohort Study with External Validation. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361375 | PubMed |
1 to 10 of 11
See all 11 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39199682
GET https://conductscience.org/api/papers/v1/39199682/references?page=2